Stock listing
KY4 Stock Price, News, Filings & Events — Kyowa Kirin Co., Ltd.
Selected listing: KY4 · GETTEX · EUR · DE
This page tracks Kyowa Kirin Co., Ltd.'s KY4:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KY4:GETTEX. KY4:GETTEX is the stock-level entry point for investors researching Kyowa Kirin Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- KY4:GETTEX
- Asset type
- Stock
- Market cap
- $7.47B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Kyowa Kirin Co., Ltd. KY4:GETTEX stock context
This page tracks Kyowa Kirin Co., Ltd.'s KY4:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KY4:GETTEX. KY4:GETTEX is the stock-level entry point for investors researching Kyowa Kirin Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Kyowa Kirin Co., Ltd.
Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans
August 31, 2026
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2026 Semi Annual
August 3, 2026
European Commission Approves Crysvita® (burosumab) for Infants with X-linked Hypophosphataemia in the European Union
July 21, 2026
FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience
June 30, 2026
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome
June 29, 2026
Research Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. investor report
Review AI stock analysis and investor report context for KY4:GETTEX.
Kyowa Kirin Co., Ltd. company profile
View the public company page for Kyowa Kirin Co., Ltd. on 6ix.
Kyowa Kirin Co., Ltd. news
Read company news and market updates connected to Kyowa Kirin Co., Ltd..
Kyowa Kirin Co., Ltd. investor events
Find investor webinars, events, and replay context for Kyowa Kirin Co., Ltd..
Alternate listings
4151:TSE
JP · JPY
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KYKOF:OTC
US · USD
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
858523:LSX
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
858523:LS
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KYKOY:OTC
US · USD
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KY4:SWB
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KY4:DUS
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KY4:FWB
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KY4:HAN
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KY4:MUN
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.
KY4:TRADEGATE
DE · EUR
Alternate listing for Kyowa Kirin Co., Ltd.; the primary context on this page is KY4:GETTEX.